FDA authorizes an extra COVID-19 dose for people with weak immune systems in the first regulatory OK for a booster shot in the U.S.

Brasil Notícia Notícia

FDA authorizes an extra COVID-19 dose for people with weak immune systems in the first regulatory OK for a booster shot in the U.S.
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 97%

The FDA late Thursday authorized an extra COVID-19 shot for people with compromised immune systems in a move that underscores the risk that the virus still poses to some vaccinated Americans.

The U.S. Food and Drug Administration late Thursday authorized an extra COVID-19 shot for people with compromised immune systems in a move that underscores the risk that the virus still poses to some vaccinated Americans.

The FDA’s announcement was made ahead of the CDC advisory committee’s meeting, which is scheduled for Friday. The committee is expected to decide whether the CDC should recommend an extra shot for people who are immunocompromised. Physicians say the most serious of these breakthrough cases are occurring in the immunocompromised, including organ-transplant patients, people undergoing chemotherapy, Americans taking chronic medications that can suppress their immune systems, and the elderly.“We do not believe that others—elderly or non-elderly who are not immunocompromised—need a vaccine right at this moment, but this is a dynamic process and the data will be evaluated,” Dr.

However, the regulator told MarketWatch that “the agency, along with the CDC, is evaluating potential options on this issue, and will share information in the near future.” The U.S. isn’t broadly tracking the number of breakthrough infections that are occurring, and it’s understood that vaccine-induced immunity can wane in some people, in part because the vaccines we have may be less protective against the more contagious delta variant.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

MarketWatch /  🏆 3. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

FDA Authorizes Covid-19 Boosters for Certain ImmunocompromisedFDA Authorizes Covid-19 Boosters for Certain ImmunocompromisedThe agency cleared giving a third dose of a Covid-19 vaccine from Pfizer or Moderna to certain immunocompromised people, likely the launch of broader efforts to better protect against evasive variants like Delta.
Consulte Mais informação »

Opinion | Why the FDA is considering Covid-19 vaccine booster shotsOpinion | Why the FDA is considering Covid-19 vaccine booster shotsOpinion | kavitapmd: As the country remains in the grips of a fourth wave with a variant of the coronavirus that has surprised many health experts, it is worth highlighting what we do and do not know about immunity and vaccine boosters. Read more:
Consulte Mais informação »

FDA set to clear third COVID-19 shot for people with weak immune systemsFDA set to clear third COVID-19 shot for people with weak immune systemsTransplant patients and others with weak immune systems often don’t get adequate responses to their first vaccine course and are at the top of the list for getting potential COVID-19 boosters.
Consulte Mais informação »

Potential Endgame Scenarios for COVID-19 | Coronavirus in ContextPotential Endgame Scenarios for COVID-19 | Coronavirus in ContextWebMD's Chief Medical Officer, John Whyte, MD, speaks with Eli Adashi, MD, Professor, Medical Science, Brown University, about the possible endgame scenarios...
Consulte Mais informação »

Unvaccinated COVID-19 patients share why they changed their minds about the shotUnvaccinated COVID-19 patients share why they changed their minds about the shotUnvaccinated Americans suffering from COVID-19 share their stories and why they changed their mind about the shot.
Consulte Mais informação »

Pac-12 says COVID-19 issues can result in forfeits in 2021Pac-12 says COVID-19 issues can result in forfeits in 2021Pac-12 teams that cannot play because of COVID-19 issues will likely be forced to forfeit games this season. The conference announced Thursday it is reinstituting its forfeiture policy after it modified its rules last season because of the pandemic. “If an institution is unable to play a contest through its own fault, it shall forfeit such contest to its opponent,” the conference said.
Consulte Mais informação »



Render Time: 2025-04-13 18:38:28